Pediatric Neurology Briefs
Published 1998 | Version v1.0.0
Journal Article Open

Methylphenidate for ADHD in Children and Adolescents

Creators

Abstract

The therapeutic effectiveness of methylphenidate (MPH) (0.3 mg/kg) in attention-deficit hyperactivity disorder (ADHD) was compared during childhood (ages 8 to 11 years) and adolescence (ages 12 to 14.5 years) in a retrospective follow-up study of 16 patients who had completed double-blind, placebo-controlled, crossover trials during two separate summer treatment programs at the Western Psychiatric Institute, University of Pittsburgh Medical Center, PA.

Files

PNB-12-23.pdf

Files (2.7 MB)

Name Size Download all
md5:e740a100a76b6f36f0dba160c39a6e81
2.7 MB Preview Download

Additional details

Identifiers

Other
PNB-12-23

Dates

Created
1998
When the item was originally created.